 | • レポートコード：GIR-2104Z03591 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、コンパニオン診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。コンパニオン診断の種類別市場規模（ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、In Situハイブリダイゼーション（ISH）、次世代シーケンシング（NGS））、用途別市場規模（病院、製薬会社、研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・コンパニオン診断の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche Holdings、Abbott Laboratories、Thermo Fisher Scientific、Agilent Technologies、Life Technologies、GE Healthcare、Agendia、Qiagen、Genomic Health、Myriad Genetics、Advanced Cell Diagnostics、Danaher、Applied Proteomics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、In Situハイブリダイゼーション（ISH）、次世代シーケンシング（NGS） ・用途別分析2016年-2026年：病院、製薬会社、研究所、その他 ・コンパニオン診断の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・コンパニオン診断のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・コンパニオン診断のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・コンパニオン診断の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・コンパニオン診断の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Companion Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Companion Diagnostics size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Companion Diagnostics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Companion Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Next Generation Sequencing (NGS)
Market segment by Application, can be divided into
Hospitals
Pharmaceutical Companies
Laboratories
Other
Market segment by players, this report covers
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Life Technologies
GE Healthcare
Agendia
Qiagen
Genomic Health
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Applied Proteomics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Companion Diagnostics
1.2 Classification of Companion Diagnostics by Type
1.2.1 Overview: Global Companion Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Companion Diagnostics Revenue Market Share by Type in 2020
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Immunohistochemistry (IHC)
1.2.5 In Situ Hybridization (ISH)
1.2.6 Next Generation Sequencing (NGS)
1.3 Global Companion Diagnostics Market by Application
1.3.1 Overview: Global Companion Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Pharmaceutical Companies
1.3.4 Laboratories
1.3.5 Other
1.4 Global Companion Diagnostics Market Size & Forecast
1.5 Global Companion Diagnostics Market Size and Forecast by Region
1.5.1 Global Companion Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Companion Diagnostics Market Size by Region, (2016-2021)
1.5.3 North America Companion Diagnostics Market Size and Prospect (2016-2026)
1.5.4 Europe Companion Diagnostics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Companion Diagnostics Market Size and Prospect (2016-2026)
1.5.6 South America Companion Diagnostics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Companion Diagnostics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Companion Diagnostics Market Drivers
1.6.2 Companion Diagnostics Market Restraints
1.6.3 Companion Diagnostics Trends Analysis
2 Company Profiles
2.1 Roche Holdings
2.1.1 Roche Holdings Details
2.1.2 Roche Holdings Major Business
2.1.3 Roche Holdings Companion Diagnostics Product and Solutions
2.1.4 Roche Holdings Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Roche Holdings Recent Developments and Future Plans
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Companion Diagnostics Product and Solutions
2.2.4 Abbott Laboratories Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Abbott Laboratories Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific Companion Diagnostics Product and Solutions
2.3.4 Thermo Fisher Scientific Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 Agilent Technologies
2.4.1 Agilent Technologies Details
2.4.2 Agilent Technologies Major Business
2.4.3 Agilent Technologies Companion Diagnostics Product and Solutions
2.4.4 Agilent Technologies Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Agilent Technologies Recent Developments and Future Plans
2.5 Life Technologies
2.5.1 Life Technologies Details
2.5.2 Life Technologies Major Business
2.5.3 Life Technologies Companion Diagnostics Product and Solutions
2.5.4 Life Technologies Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Life Technologies Recent Developments and Future Plans
2.6 GE Healthcare
2.6.1 GE Healthcare Details
2.6.2 GE Healthcare Major Business
2.6.3 GE Healthcare Companion Diagnostics Product and Solutions
2.6.4 GE Healthcare Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 GE Healthcare Recent Developments and Future Plans
2.7 Agendia
2.7.1 Agendia Details
2.7.2 Agendia Major Business
2.7.3 Agendia Companion Diagnostics Product and Solutions
2.7.4 Agendia Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Agendia Recent Developments and Future Plans
2.8 Qiagen
2.8.1 Qiagen Details
2.8.2 Qiagen Major Business
2.8.3 Qiagen Companion Diagnostics Product and Solutions
2.8.4 Qiagen Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Qiagen Recent Developments and Future Plans
2.9 Genomic Health
2.9.1 Genomic Health Details
2.9.2 Genomic Health Major Business
2.9.3 Genomic Health Companion Diagnostics Product and Solutions
2.9.4 Genomic Health Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Genomic Health Recent Developments and Future Plans
2.10 Myriad Genetics
2.10.1 Myriad Genetics Details
2.10.2 Myriad Genetics Major Business
2.10.3 Myriad Genetics Companion Diagnostics Product and Solutions
2.10.4 Myriad Genetics Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Myriad Genetics Recent Developments and Future Plans
2.11 Advanced Cell Diagnostics
2.11.1 Advanced Cell Diagnostics Details
2.11.2 Advanced Cell Diagnostics Major Business
2.11.3 Advanced Cell Diagnostics Companion Diagnostics Product and Solutions
2.11.4 Advanced Cell Diagnostics Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Advanced Cell Diagnostics Recent Developments and Future Plans
2.12 Danaher
2.12.1 Danaher Details
2.12.2 Danaher Major Business
2.12.3 Danaher Companion Diagnostics Product and Solutions
2.12.4 Danaher Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Danaher Recent Developments and Future Plans
2.13 Applied Proteomics
2.13.1 Applied Proteomics Details
2.13.2 Applied Proteomics Major Business
2.13.3 Applied Proteomics Companion Diagnostics Product and Solutions
2.13.4 Applied Proteomics Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Applied Proteomics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Companion Diagnostics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Companion Diagnostics Players Market Share
3.2.2 Top 10 Companion Diagnostics Players Market Share
3.2.3 Market Competition Trend
3.3 Companion Diagnostics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Companion Diagnostics Revenue and Market Share by Type (2016-2021)
4.2 Global Companion Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Companion Diagnostics Revenue Market Share by Application (2016-2021)
5.2 Companion Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Companion Diagnostics Revenue by Type (2016-2026)
6.2 North America Companion Diagnostics Revenue by Application (2016-2026)
6.3 North America Companion Diagnostics Market Size by Country
6.3.1 North America Companion Diagnostics Revenue by Country (2016-2026)
6.3.2 United States Companion Diagnostics Market Size and Forecast (2016-2026)
6.3.3 Canada Companion Diagnostics Market Size and Forecast (2016-2026)
6.3.4 Mexico Companion Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Companion Diagnostics Revenue by Type (2016-2026)
7.2 Europe Companion Diagnostics Revenue by Application (2016-2026)
7.3 Europe Companion Diagnostics Market Size by Country
7.3.1 Europe Companion Diagnostics Revenue by Country (2016-2026)
7.3.2 Germany Companion Diagnostics Market Size and Forecast (2016-2026)
7.3.3 France Companion Diagnostics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Companion Diagnostics Market Size and Forecast (2016-2026)
7.3.5 Russia Companion Diagnostics Market Size and Forecast (2016-2026)
7.3.6 Italy Companion Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Companion Diagnostics Revenue by Type (2016-2026)
8.2 Asia-Pacific Companion Diagnostics Revenue by Application (2016-2026)
8.3 Asia-Pacific Companion Diagnostics Market Size by Region
8.3.1 Asia-Pacific Companion Diagnostics Revenue by Region (2016-2026)
8.3.2 China Companion Diagnostics Market Size and Forecast (2016-2026)
8.3.3 Japan Companion Diagnostics Market Size and Forecast (2016-2026)
8.3.4 South Korea Companion Diagnostics Market Size and Forecast (2016-2026)
8.3.5 India Companion Diagnostics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Companion Diagnostics Market Size and Forecast (2016-2026)
8.3.7 Australia Companion Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Companion Diagnostics Revenue by Type (2016-2026)
9.2 South America Companion Diagnostics Revenue by Application (2016-2026)
9.3 South America Companion Diagnostics Market Size by Country
9.3.1 South America Companion Diagnostics Revenue by Country (2016-2026)
9.3.2 Brazil Companion Diagnostics Market Size and Forecast (2016-2026)
9.3.3 Argentina Companion Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Companion Diagnostics Revenue by Type (2016-2026)
10.2 Middle East & Africa Companion Diagnostics Revenue by Application (2016-2026)
10.3 Middle East & Africa Companion Diagnostics Market Size by Country
10.3.1 Middle East & Africa Companion Diagnostics Revenue by Country (2016-2026)
10.3.2 Turkey Companion Diagnostics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Companion Diagnostics Market Size and Forecast (2016-2026)
10.3.4 UAE Companion Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Companion Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Companion Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Companion Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Companion Diagnostics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Companion Diagnostics Revenue Market Share by Region (2021-2026)
Table 6. Roche Holdings Corporate Information, Head Office, and Major Competitors
Table 7. Roche Holdings Major Business
Table 8. Roche Holdings Companion Diagnostics Product and Solutions
Table 9. Roche Holdings Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 11. Abbott Laboratories Major Business
Table 12. Abbott Laboratories Companion Diagnostics Product and Solutions
Table 13. Abbott Laboratories Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 15. Thermo Fisher Scientific Major Business
Table 16. Thermo Fisher Scientific Companion Diagnostics Product and Solutions
Table 17. Thermo Fisher Scientific Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 19. Agilent Technologies Major Business
Table 20. Agilent Technologies Companion Diagnostics Product and Solutions
Table 21. Agilent Technologies Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Life Technologies Corporate Information, Head Office, and Major Competitors
Table 23. Life Technologies Major Business
Table 24. Life Technologies Companion Diagnostics Product and Solutions
Table 25. Life Technologies Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. GE Healthcare Corporate Information, Head Office, and Major Competitors
Table 27. GE Healthcare Major Business
Table 28. GE Healthcare Companion Diagnostics Product and Solutions
Table 29. GE Healthcare Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Agendia Corporate Information, Head Office, and Major Competitors
Table 31. Agendia Major Business
Table 32. Agendia Companion Diagnostics Product and Solutions
Table 33. Agendia Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Qiagen Corporate Information, Head Office, and Major Competitors
Table 35. Qiagen Major Business
Table 36. Qiagen Companion Diagnostics Product and Solutions
Table 37. Qiagen Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Genomic Health Corporate Information, Head Office, and Major Competitors
Table 39. Genomic Health Major Business
Table 40. Genomic Health Companion Diagnostics Product and Solutions
Table 41. Genomic Health Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 43. Myriad Genetics Major Business
Table 44. Myriad Genetics Companion Diagnostics Product and Solutions
Table 45. Myriad Genetics Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Advanced Cell Diagnostics Corporate Information, Head Office, and Major Competitors
Table 47. Advanced Cell Diagnostics Major Business
Table 48. Advanced Cell Diagnostics Companion Diagnostics Product and Solutions
Table 49. Advanced Cell Diagnostics Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Danaher Corporate Information, Head Office, and Major Competitors
Table 51. Danaher Major Business
Table 52. Danaher Companion Diagnostics Product and Solutions
Table 53. Danaher Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Applied Proteomics Corporate Information, Head Office, and Major Competitors
Table 55. Applied Proteomics Major Business
Table 56. Applied Proteomics Companion Diagnostics Product and Solutions
Table 57. Applied Proteomics Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Companion Diagnostics Revenue (USD Million) by Players (2019-2021)
Table 59. Global Companion Diagnostics Revenue Share by Players (2019-2021)
Table 60. Breakdown of Companion Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Companion Diagnostics Players Head Office, Products and Services Provided
Table 62. Companion Diagnostics Mergers & Acquisitions in the Past Five Years
Table 63. Companion Diagnostics New Entrants and Expansion Plans
Table 64. Global Companion Diagnostics Revenue (USD Million) by Type (2016-2021)
Table 65. Global Companion Diagnostics Revenue Share by Type (2016-2021)
Table 66. Global Companion Diagnostics Revenue Forecast by Type (2021-2026)
Table 67. Global Companion Diagnostics Revenue by Application (2016-2021)
Table 68. Global Companion Diagnostics Revenue Forecast by Application (2021-2026)
Table 69. North America Companion Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Companion Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Companion Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Companion Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Companion Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Companion Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Companion Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Companion Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Companion Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Companion Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Companion Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Companion Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Companion Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Companion Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Companion Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Companion Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Companion Diagnostics Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Companion Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Companion Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Companion Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Companion Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Companion Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Companion Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Companion Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Companion Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Companion Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Companion Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Companion Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Companion Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Companion Diagnostics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Companion Diagnostics Picture
Figure 2. Global Companion Diagnostics Revenue Market Share by Type in 2020
Figure 3. Polymerase Chain Reaction (PCR)
Figure 4. Immunohistochemistry (IHC)
Figure 5. In Situ Hybridization (ISH)
Figure 6. Next Generation Sequencing (NGS)
Figure 7. Companion Diagnostics Revenue Market Share by Application in 2020
Figure 8. Hospitals Picture
Figure 9. Pharmaceutical Companies Picture
Figure 10. Laboratories Picture
Figure 11. Other Picture
Figure 12. Global Companion Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Companion Diagnostics Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Companion Diagnostics Revenue Market Share by Region (2016-2026)
Figure 15. Global Companion Diagnostics Revenue Market Share by Region in 2020
Figure 16. North America Companion Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Companion Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Companion Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Companion Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Companion Diagnostics Market Drivers
Figure 21. Companion Diagnostics Market Restraints
Figure 22. Companion Diagnostics Market Trends
Figure 23. Roche Holdings Recent Developments and Future Plans
Figure 24. Abbott Laboratories Recent Developments and Future Plans
Figure 25. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 26. Agilent Technologies Recent Developments and Future Plans
Figure 27. Life Technologies Recent Developments and Future Plans
Figure 28. GE Healthcare Recent Developments and Future Plans
Figure 29. Agendia Recent Developments and Future Plans
Figure 30. Qiagen Recent Developments and Future Plans
Figure 31. Genomic Health Recent Developments and Future Plans
Figure 32. Myriad Genetics Recent Developments and Future Plans
Figure 33. Advanced Cell Diagnostics Recent Developments and Future Plans
Figure 34. Danaher Recent Developments and Future Plans
Figure 35. Applied Proteomics Recent Developments and Future Plans
Figure 37. Global Companion Diagnostics Revenue Share by Players in 2020
Figure 38. Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 39. Global Top 3 Players Companion Diagnostics Revenue Market Share in 2020
Figure 40. Global Top 10 Players Companion Diagnostics Revenue Market Share in 2020
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 42. Global Companion Diagnostics Revenue Share by Type in 2020
Figure 43. Global Companion Diagnostics Market Share Forecast by Type (2021-2026)
Figure 44. Global Companion Diagnostics Revenue Share by Application in 2020
Figure 45. Global Companion Diagnostics Market Share Forecast by Application (2021-2026)
Figure 46. North America Companion Diagnostics Sales Market Share by Type (2016-2026)
Figure 47. North America Companion Diagnostics Sales Market Share by Application (2016-2026)
Figure 48. North America Companion Diagnostics Revenue Market Share by Country (2016-2026)
Figure 49. United States Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Canada Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Mexico Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Europe Companion Diagnostics Sales Market Share by Type (2016-2026)
Figure 53. Europe Companion Diagnostics Sales Market Share by Application (2016-2026)
Figure 54. Europe Companion Diagnostics Revenue Market Share by Country (2016-2026)
Figure 55. Germany Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Companion Diagnostics Sales Market Share by Type (2016-2026)
Figure 61. Asia-Pacific Companion Diagnostics Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Companion Diagnostics Revenue Market Share by Region (2016-2026)
Figure 63. China Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South Korea Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Companion Diagnostics Sales Market Share by Type (2016-2026)
Figure 70. South America Companion Diagnostics Sales Market Share by Application (2016-2026)
Figure 71. South America Companion Diagnostics Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East and Africa Companion Diagnostics Sales Market Share by Type (2016-2026)
Figure 75. Middle East and Africa Companion Diagnostics Sales Market Share by Application (2016-2026)
Figure 76. Middle East and Africa Companion Diagnostics Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. UAE Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界のコンパニオン診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Companion Diagnostics Market The global Companion Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report…- 世界のデジタルコンパニオン診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Digital Companion Diagnostics Market The global Digital Companion Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
- 世界のデジタルコンパニオン診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Digital Companion Diagnostics Market The global Digital Companion Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
- 世界のデジタル式コンパニオン診断市場 2021：企業別、地域別、種類・用途別 The Digital Companion Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の薬理ゲノミクス技術/セラノスティクス/コンパニオン診断（CDx）市場 2021：企業別、地域別、種類・用途別 The Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market pla…